Application number | Title of the application | Filing Date | Status |
---|
07/846941 | CARBOSTYRIL DERIVATIVES | Mar 5, 1992 | Abandoned |
Array
(
[id] => 2994407
[patent_doc_number] => 05366969
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-11-22
[patent_title] => 'Amidine group containing monocycloheteracyclic or bicycloheterocyclic diphosphonic acid derivatives and medicaments containing these compounds'
[patent_app_type] => 1
[patent_app_number] => 7/829019
[patent_app_country] => US
[patent_app_date] => 1992-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3034
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 285
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/366/05366969.pdf
[firstpage_image] =>[orig_patent_app_number] => 829019
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/829019 | Amidine group containing monocycloheteracyclic or bicycloheterocyclic diphosphonic acid derivatives and medicaments containing these compounds | Mar 5, 1992 | Issued |
Array
(
[id] => 3412018
[patent_doc_number] => 05438135
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-08-01
[patent_title] => 'Water-soluble tetraazaporphins and fluorochrome for labeling'
[patent_app_type] => 1
[patent_app_number] => 7/846169
[patent_app_country] => US
[patent_app_date] => 1992-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 56
[patent_figures_cnt] => 56
[patent_no_of_words] => 21933
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 489
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/438/05438135.pdf
[firstpage_image] =>[orig_patent_app_number] => 846169
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/846169 | Water-soluble tetraazaporphins and fluorochrome for labeling | Mar 4, 1992 | Issued |
07/844173 | RETINAL,DERIVATIVES AND THEIR THERAPEUTIC USE | Mar 1, 1992 | Abandoned |
Array
(
[id] => 3097198
[patent_doc_number] => 05298620
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-03-29
[patent_title] => 'Process for the destruction of cyanuric fluoride in the residues obtained during its preparation'
[patent_app_type] => 1
[patent_app_number] => 7/834303
[patent_app_country] => US
[patent_app_date] => 1992-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1694
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/298/05298620.pdf
[firstpage_image] =>[orig_patent_app_number] => 834303
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/834303 | Process for the destruction of cyanuric fluoride in the residues obtained during its preparation | Feb 18, 1992 | Issued |
07/829865 | MANGANESE(II) COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS EFFECTIVE AS CATALYSTS FOR DISMUTATING SUPEROXIDE | Feb 2, 1992 | Abandoned |
Array
(
[id] => 3081938
[patent_doc_number] => 05284647
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-02-08
[patent_title] => 'Mesotetraphenylporphyrin complex compounds, process for their production and pharmaceutical agents containing them'
[patent_app_type] => 1
[patent_app_number] => 7/817892
[patent_app_country] => US
[patent_app_date] => 1992-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20919
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/284/05284647.pdf
[firstpage_image] =>[orig_patent_app_number] => 817892
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/817892 | Mesotetraphenylporphyrin complex compounds, process for their production and pharmaceutical agents containing them | Jan 8, 1992 | Issued |
07/793414 | AMINO ACID ANALOG CCK ANTAGONISTS | Jan 1, 1992 | Abandoned |
Array
(
[id] => 3113894
[patent_doc_number] => 05409893
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-04-25
[patent_title] => 'Ruthenium(III) complexes as antineoplastic agents'
[patent_app_type] => 1
[patent_app_number] => 7/773939
[patent_app_country] => US
[patent_app_date] => 1991-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4549
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 253
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/409/05409893.pdf
[firstpage_image] =>[orig_patent_app_number] => 773939
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/773939 | Ruthenium(III) complexes as antineoplastic agents | Dec 12, 1991 | Issued |
Array
(
[id] => 3023497
[patent_doc_number] => 05316757
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-05-31
[patent_title] => 'Synthesis of polyazamacrocycles with more than one type of side-chain chelating groups'
[patent_app_type] => 1
[patent_app_number] => 7/808845
[patent_app_country] => US
[patent_app_date] => 1991-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 36
[patent_no_of_words] => 16563
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/316/05316757.pdf
[firstpage_image] =>[orig_patent_app_number] => 808845
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/808845 | Synthesis of polyazamacrocycles with more than one type of side-chain chelating groups | Dec 12, 1991 | Issued |
Array
(
[id] => 2961510
[patent_doc_number] => 05273974
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-12-28
[patent_title] => 'Condensed heterocyclic compounds, their production and use'
[patent_app_type] => 1
[patent_app_number] => 7/796430
[patent_app_country] => US
[patent_app_date] => 1991-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27529
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/273/05273974.pdf
[firstpage_image] =>[orig_patent_app_number] => 796430
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/796430 | Condensed heterocyclic compounds, their production and use | Nov 21, 1991 | Issued |
07/761734 | OXIDATIVE PREPARATION OF 3,5-SECOANDROST-5-ONE-3,17BETA-DIOIC ACID | Sep 5, 1991 | Abandoned |
Array
(
[id] => 3000095
[patent_doc_number] => 05359072
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-10-25
[patent_title] => 'Nonlinearly optically active compounds'
[patent_app_type] => 1
[patent_app_number] => 7/714585
[patent_app_country] => US
[patent_app_date] => 1991-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2115
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/359/05359072.pdf
[firstpage_image] =>[orig_patent_app_number] => 714585
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/714585 | Nonlinearly optically active compounds | Jun 12, 1991 | Issued |
Array
(
[id] => 3429511
[patent_doc_number] => 05403928
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-04-04
[patent_title] => 'Fluorescent marker components and fluorescent probes'
[patent_app_type] => 1
[patent_app_number] => 7/701449
[patent_app_country] => US
[patent_app_date] => 1991-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9305
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/403/05403928.pdf
[firstpage_image] =>[orig_patent_app_number] => 701449
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/701449 | Fluorescent marker components and fluorescent probes | May 14, 1991 | Issued |
07/701465 | FLUORESCENT DYES FREE OF AGGREGATION AND SERUM BINDING | May 14, 1991 | Abandoned |
07/698374 | TREATMENT OF ANDROGENIC ALOPECIA WITH 17 BETA-N- MONOSUBSTITUTED- CARBOMOYL-4-AZA-5 ALPHA-ANDROST-1-EN-3-ONES | May 8, 1991 | Abandoned |
07/659560 | SOFT STEROIDS HAVING ANTI-INFLAMMATORY ACTIVITY | Feb 21, 1991 | Abandoned |
Array
(
[id] => 3507793
[patent_doc_number] => 05514794
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-05-07
[patent_title] => 'Antibody-drug conjugates'
[patent_app_type] => 1
[patent_app_number] => 7/644366
[patent_app_country] => US
[patent_app_date] => 1991-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15704
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/514/05514794.pdf
[firstpage_image] =>[orig_patent_app_number] => 644366
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/644366 | Antibody-drug conjugates | Jan 21, 1991 | Issued |
07/630984 | CONDENSED HETEROCYCLIC COMPOUNDS, THEIR PRODUCTION AND USE | Dec 19, 1990 | Abandoned |
07/541806 | 11BETA-ARYL-4-ESTRENES, PROCESS FOR THEIR PRODUCTION AS WELL AS THEIR USE AS PHARMACEUTICAL AGENTS | Jun 20, 1990 | Abandoned |